BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9867365)

  • 1. [Fli-1 (Friend leukemia integration 1). Oncogene].
    Bull Cancer; 1998 Oct; 85(10):830. PubMed ID: 9867365
    [No Abstract]   [Full Text] [Related]  

  • 2. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
    Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
    Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of Fli-1 in normal cell function and malignant transformation.
    Truong AH; Ben-David Y
    Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
    Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
    Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
    Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
    Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EWS fli-1 antisense nanocapsules inhibits ewing sarcoma-related tumor in mice.
    Lambert G; Bertrand JR; Fattal E; Subra F; Pinto-Alphandary H; Malvy C; Auclair C; Couvreur P
    Biochem Biophys Res Commun; 2000 Dec; 279(2):401-6. PubMed ID: 11118299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
    Bertolotti A; Bell B; Tora L
    Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
    Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
    Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin.
    Siligan C; Ban J; Bachmaier R; Spahn L; Kreppel M; Schaefer KL; Poremba C; Aryee DN; Kovar H
    Oncogene; 2005 Apr; 24(15):2512-24. PubMed ID: 15735734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
    Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
    Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of expression of ets-1 and fli-1 proto-oncogenes in murine embryonic stem cells, induced to differentiation by retinoic acid].
    Iakubovich EI; Evtushenko VI
    Mol Biol (Mosk); 1999; 33(5):861-5. PubMed ID: 10579191
    [No Abstract]   [Full Text] [Related]  

  • 12. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of an oncogenic fusion protein by a viral gene--a new chapter in an old story.
    Kirn D; Hermiston T
    Nat Med; 1999 Sep; 5(9):991-2. PubMed ID: 10470071
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance against Friend leukemia virus-induced leukemogenesis in DNA-dependent protein kinase (DNA-PK)-deficient scid mice associated with defective viral integration at the Spi-1 and Fli-1 site.
    Hasegawa M; Yamaguchi S; Aizawa S; Ikeda H; Tatsumi K; Noda Y; Hirokawa K; Kitagawa M
    Leuk Res; 2005 Aug; 29(8):933-42. PubMed ID: 15978944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ETS family member Tel antagonizes the Fli-1 phenotype in hematopoietic cells.
    Kwiatkowski BA; Zielinska-Kwiatkowska AG; Bauer TR; Hickstein DD
    Blood Cells Mol Dis; 2000 Feb; 26(1):84-90. PubMed ID: 10772879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contiguous arrangement of p45 NFE2, HnRNP A1, and HP1 alpha on mouse chromosome 15 and human chromosome 12: evidence for suppression of these genes due to retroviral integration within the Fli-2 locus.
    Li YJ; Pak BJ; Higgins RR; Lu SJ; Ben-David Y
    Genes Chromosomes Cancer; 2001 Jan; 30(1):91-5. PubMed ID: 11107181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ets and retroviruses - transduction and activation of members of the Ets oncogene family in viral oncogenesis.
    Blair DG; Athanasiou M
    Oncogene; 2000 Dec; 19(55):6472-81. PubMed ID: 11175363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia.
    Mélet F; Motro B; Rossi DJ; Zhang L; Bernstein A
    Mol Cell Biol; 1996 Jun; 16(6):2708-18. PubMed ID: 8649378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.
    Matsumoto Y; Tanaka K; Nakatani F; Matsunobu T; Matsuda S; Iwamoto Y
    Br J Cancer; 2001 Mar; 84(6):768-75. PubMed ID: 11259090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.